Sonoma Pharmaceuticals's total assets for Q3 2026 were $13.62M, a decrease of -1.68% from the previous quarter. SNOA total liabilities were $10.19M for the fiscal quarter, a 1.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.